VSBC — Vitaspring Biomedical Co. Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $206.52m
- $206.50m
- $5.61m
Annual cashflow statement for Vitaspring Biomedical Co., fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2018 January 31st | 2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.006 | -0.022 | 0.007 | -0.425 | 1.26 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | — | -0.017 | 0.434 | 0.167 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.006 | -0.012 | 0.01 | -0.051 | -1.36 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0 | -0.034 | -0 | -0.042 | 0.085 |
| Capital Expenditures | -0.002 | 0 | — | — | -0.073 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | 0 | — | — | -0.073 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.006 | 0.029 | 0 | 0.088 | 0.05 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.005 | -0.005 | -0 | 0.045 | 0.062 |